Hasil Pencarian - David Pinato

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    515 A phase 1 study of myeloid modulating agent MTL-CEBPA in combination with pembrolizumab in adult patients with advanced solid tumours

    515 A phase 1 study of myeloid modulating agent MTL-CEBPA in combination with pembrolizumab in adult patients with advanced solid tumours oleh Ruth Plummer, Alessio Cortellini, Debashis Sarker, Ilian Tchakov, John Rossi, David Pinato, Mikael Sodergren, Vikash Reebye, Duncan Spalding, Nina Raulf, Laura Sinigaglia, Thomas Talbot, Antonio D’Alessio, Robert Habib, Nagy Habib

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    529 Phase 1 study of INCB086550, an oral PD-L1 inhibitor, in immune-checkpoint naive patients with advanced solid tumors

    529 Phase 1 study of INCB086550, an oral PD-L1 inhibitor, in immune-checkpoint naive patients with advanced solid tumors oleh Rebecca Kristeleit, Howard Burris, Kristen Spencer, Sarina Piha-Paul, Hans Prenen, Tara Mitchell, David Pinato, Solmaz Sahebjam, Donna Graham, Nuria Kotecki, Eric Van Cutsem, Brant Delafontaine, Thomas Karasic, Jeannie Daniel, Kevin O’Hayer, Ryan Geschwindt

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study

    32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international ob... oleh Abdul Rafeh Naqash, Mahvish Muzaffar, Shravanti Macherla, Alessio Cortellini, James Clark, Emma Mi, Sanna Livanainen, Daria Gramenitskaya, Kevin O’Brien, Jussi Koivunen, Sweta Jonnalagadda, Shanker Polsani, Rahim Jiwani, Nitika Sharma, Chipman Stroud, Paul Walker, David Pinato

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study

    239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study oleh Abdul Rafeh Naqash, Shravanti Macherla, Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Domenico Mallardo, Thomas Marron, Douglas Johnson, Christopher Hoimes, Vito Vanella, Toni Choueiri, Paolo Ascierto, Ella Daniels, Haocan Song, Fei Ye, Tamara Sussman, Domenico Galetta, Anwaar Saeed, Annamaria Catino, Carlo Genova, Pamela Pizzutilo, Giuseppe Lamberti, David Pinato, Rebecca Irlmeier, Caroline Nebhan, Weijie Ma, Teja Ganta, Neha Debnath, Maluki Radford, Asrar Alahmadi, Akiva Diamond, Nikhil Ramaiya, Carolyn Presley, Dwight Owen, Sarah Abou Alaiwi, Amin Nassar, Chiara Casartelli, Maria Giovanna Dal Bello, Foteini Kalofonou

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: